The impact of community asymptomatic rapid antigen testing on COVID-19 hospital admissions: a synthetic control study
View ORCID ProfileXingna Zhang, View ORCID ProfileBen Barr, View ORCID ProfileMark Green, David Hughes, Matthew Ashton, Dimitrios Charalampopoulos, Marta García-Fiñana, View ORCID ProfileIain Buchan
doi: https://doi.org/10.1101/2022.04.19.22274050
Xingna Zhang
1Research Associate, Department of Public Health, Policy & Systems, University of Liverpool, Liverpool, UK
Ben Barr
2Professor in Applied Public Health Research, Department of Public Health, Policy & Systems, University of Liverpool, Liverpool, UK
Mark Green
3Reader in Health Geography, Department of Geography & Planning, University of Liverpool, Liverpool, UK
David Hughes
4Lecturer in Health Data Science, Department of Health Data Science, University of Liverpool, Liverpool, UK
Matthew Ashton
5Director of Public Health, Liverpool City Council, Liverpool, UK
Dimitrios Charalampopoulos
6Lecturer in Public Health, Department of Public Health, Policy & Systems, University of Liverpool, Liverpool, UK
Marta García-Fiñana
7Professor of Health Data Science, Department of Health Data Science, University of Liverpool, Liverpool, UK
Iain Buchan
8Chair in Public Health and Clinical Informatics, Department of Public Health, Policy & Systems, University of Liverpool, Liverpool, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All the data we used are publicly accessible from https://coronavirus.data.gov.uk/ and statistical code is available from the corresponding author upon request.
Posted April 21, 2022.
The impact of community asymptomatic rapid antigen testing on COVID-19 hospital admissions: a synthetic control study
Xingna Zhang, Ben Barr, Mark Green, David Hughes, Matthew Ashton, Dimitrios Charalampopoulos, Marta García-Fiñana, Iain Buchan
medRxiv 2022.04.19.22274050; doi: https://doi.org/10.1101/2022.04.19.22274050
The impact of community asymptomatic rapid antigen testing on COVID-19 hospital admissions: a synthetic control study
Xingna Zhang, Ben Barr, Mark Green, David Hughes, Matthew Ashton, Dimitrios Charalampopoulos, Marta García-Fiñana, Iain Buchan
medRxiv 2022.04.19.22274050; doi: https://doi.org/10.1101/2022.04.19.22274050
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2649)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12229)
- Forensic Medicine (10)
- Gastroenterology (760)
- Genetic and Genomic Medicine (4105)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2658)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (438)
- Neurology (3884)
- Nursing (209)
- Nutrition (578)
- Oncology (2033)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6532)
- Radiology and Imaging (1405)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (449)
- Toxicology (53)
- Transplantation (185)
- Urology (165)